BioPacific Partners is deeply embedded in the pharma innovation community across Australia and New Zealand, and offers a range of services to help you find relevant opportunities to enhance your pharmaceutical product development pipeline. Our team has a strong combination of commercial and academic experience in the pharmaceutical and biotech sector.
The complex nature of pharmaceutical innovation means that BioPacific Partners works on a case-by-case basis to provide a service tailored to the specific therapeutic indication and stage of development our partners are seeking. This can include project-based work, transaction services, and long-term partnerships.
Case study – landscape review
For the example below, a global top five pharmaceutical company partnered with BioPacific Partners to provide a comprehensive landscape review of technologies across selected indications. Over six months, we screened drug development assets from listed and private companies, universities and research institutes, from pre-clinical to clinical stage. BioPacific’s activity resulted in 28 actively monitored opportunities and six immediate engagements.
“BioPacific has delivered one of the highest scouting ‘hit rates’ we’ve ever seen”
Working with our region
Australia and New Zealand are home to 10% of the top 100 life sciences universities, several globally recognised biomedical research institutes and more than 200 health technology companies. This makes our region a rich hunting ground for pharmaceutical innovations with great depth and diversity spanning all major disease areas. Particular areas that BioPacific Partners is well connected in include:
- Oncology including immuno-oncology
- Immunity & inflammation
- Metabolism & cardiovascular
- Infectious diseases
- Rare diseases
- Technology platforms.
Please contact us for more detail on how we can help.